article thumbnail

Winning the Battle Against Atherosclerosis: Practical, Proactive Solutions

Cardiometabolic Health Congress

Atherosclerosis (ASVD) remains a leading driver of cardiovascular disease (CVD), a global health challenge that claims millions of lives each year. Policy Advocacy: Supporting Prevention on a Broader Scale Public health policies to reduce environmental risk factors (e.g.,

article thumbnail

Research status of subclinical hypothyroidism promoting the development and progression of cardiovascular diseases

Frontiers in Cardiovascular Medicine

In recent years, the incidence of cardiovascular disease (CVD) has risen steadily, significantly impacting public health. Evidence suggests SCH may exacerbate atherosclerosis and cardiac dysfunction through mechanisms such as increased LDL synthesis, oxidative stress, and impaired vascular endothelial function.

article thumbnail

Top Cardiology Conferences in 2025

Cardiology Update

This event encompasses various facets, including public health, primary care, secondary prevention, rehabilitation, sports cardiology, and exercise. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease.

article thumbnail

Top Cardiology Conferences in 2024

Cardiology Update

This event encompasses various facets, including public health, primary care, secondary prevention, rehabilitation, sports cardiology, and exercise. EAS Congress explores the latest research developments into the causes of atherosclerosis and related vascular disease. Hashtag: #ICNCCT2024 7.

article thumbnail

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Circulation

The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives.

article thumbnail

Researchers Find ApoB Test May be More Accurate Measure of Heart Disease Risk

DAIC

School of Public Health at UT Southwestern. guidelines may overlook people who are at higher risk of developing atherosclerosis despite normal metabolic health markers. The study includes an online calculator for the public to estimate apoB levels based on the LDL-C level. Physicians following U.S.

article thumbnail

Cholesterol’s Star Role in Dementia Prevention: New Insights from the 2024 Lancet Dementia Report 

Cardiometabolic Health Congress

The 2024 report from the Lancet Standing Commission on Dementia Prevention, Intervention, and Care brings promising developments for healthcare professionals and public health advocates. The Takeaway The 2024 Lancet Commission report is a call to action for healthcare providers and public health advocates.